Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.005 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
10000
Market Cap
1.44M

Momentum Score

…

Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was established in 2004 and is headquartered in Orlando, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.01
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Cann American Corp (CNNA.US) on the OTC Pink are limited and its current business operations are not clearly documented. If the company remains active in cannabis or related services, long-term drivers that could support growth include legalization trends and rising consumer demand, which may attract investors seeking sector exposure.
Key risks are limited transparency and outdated filings, very low liquidity on the OTC Pink market, regulatory uncertainty in cannabis markets, and potential capital constraints or dilution.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.01M
Revenue Per Share
-
Gross Profit TTM
0.02M
Debt / Equity
-
ROE
-259.65%
Net Debt
-
ROCE
1826.75%
Diluted EPS TTM
-17.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Income before tax - - - -0.01M -0.00M
Net income - - - -0.01M -0.00M
Selling general administrative - - - 0.09M 0.02M
Gross profit - - - 0.09M 0.02M
Ebit -0.15M -0.20M -0.01M -0.01M -0.00M
Operating income - - - -0.01M -0.00M
Interest expense - - 0.00M 0.00M 0.00M
Total revenue - - - 0.12M 0.03M
Total operating expenses - - - 0.12M 0.03M
Cost of revenue - - - 0.03M 0.01M
Net income from continuing ops - - - -0.01M -0.00M
Net income applicable to common shares 3.82M 10.54M -0.25M -0.01M -0.00M
Breakdown 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Total assets - - - 0.19M 0.20M
Other current assets 0.05M 0.20M - - -
Total liab - - - 0.20M 0.20M
Total stockholder equity - - - -0.01M -0.00M
Other current liab 2.51M 6.45M - - -
Common stock 0.95M 0.93M 0.90M 0.90M 0.90M
Retained earnings -8.37M -12.19M -5.11M -4.86M -4.85M
Good will - - - 0.19M 0.19M
Other assets - - 0.00M - -
Cash - - - 0.00M 0.00M
Total current liabilities 2.88M 6.85M 0.00M 0.20M -
Short term debt - - - 0.20M -
Short long term debt - - - 0.20M -
Property plant equipment - - 0.00M 0.01M 0.01M
Total current assets 0.07M 0.21M 0.05M 0.00M 0.00M
Net tangible assets -2.81M -6.65M 0.04M -0.19M -0.19M
Long term debt - - - - 0.20M
Accounts payable - - 0.00M 0.00M -
Breakdown 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Change to liabilities 0.00M -0.06M -0.00M 0.00M 0.00M
Total cashflows from investing activities - - 0.24M 0.24M -0.20M
Net borrowings 0.10M 0.22M 0.00M 0.00M 0.20M
Total cash from financing activities 0.01M 0.28M 0.05M 0.05M 0.20M
Change to operating activities 0.15M -0.09M -0.09M -0.09M -
Net income 3.82M 10.54M -0.25M -0.01M -0.00M
Change in cash 0.01M -0.07M 0.04M -0.00M 0.00M
Total cash from operating activities 0.01M -0.34M -0.24M -0.00M 0.00M
Depreciation - - 0.01M 0.00M 0.00M
Other cashflows from financing activities -0.09M 0.05M 0.05M 0.05M -
Change to netincome -4.00M -11.01M -0.00M -0.00M -0.00M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.01M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
CNNA
Cann American Corp
-
-%
0.01 - - 0.03 0.00 -0.00
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 23.11

Profile*

Cann American Corp

Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was established in 2004 and is headquartered in Orlando, Florida.

121 South Orange Avenue, Orlando, FL, United States, 32801

888 722 1247

1

Name Title Year Born
Mr. Alexander Woods-Leo CEO, Pres, Sec. & Director NA
Mr. Jason R. Tucker CFO, CEO, Secretary, Treasurer & Director 1977
Mr. Michael G. Kramer President, COO and Director 1979

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…